Hospice Care in Glendale, CA
33 Hospice found. Showing 21 - 33
 Cb Homecare Hospice Medicare Approved Location: 512 East Wilson Ave, Suite 204, Glendale, California 91206 Phone: (818) 241-5910 |
New Horizon Hospice, Inc Medicare Approved Location: 1012 East Colorado St, Suite 290, Glendale, California 91205 Phone: (818) 244-5360 |
Omega Hospice Care Inc Medicare Approved Location: 1241 S Glendale Ave, Suite B 204c, Glendale, California 91205 Phone: (818) 807-8884 |
Light Days Hospice, Inc Medicare Approved Location: 541 W Colorado St Suite 206, Glendale, California 91204 Phone: (818) 240-8875 |
Tc Palliative And Hospice Care Medicare Approved Location: 1428 East Colorado St, Suite F, Glendale, California 91205 Phone: (818) 649-1900 |
Salute Hospice Inc. Medicare Approved Location: 1007 S Central Ave Suite 204, Glendale, California 91204 Phone: (818) 638-8522 |
Bva Hospice Care, Inc Medicare Approved Location: 315 Arden Ave Suite 25, Glendale, California 91203 Phone: (818) 550-9950 |
American Hospice Services, Inc Medicare Approved Location: 1545 North Verdugo Rd., Suite 108, Glendale, California 91208 Phone: (818) 672-6562 |
Care Connection Hospice Medicare Approved Location: 805 East Broadway, Suite F, Glendale, California 91205 Phone: (818) 244-5667 |
Van Nuys Hospice Care, Inc Medicare Approved Location: 1555 N Verdugo Rd Suite 202, Glendale, California 91208 Phone: (818) 243-3097 |
Socal Hospice Services, Inc Medicare Approved Location: 1545 N. Verdugo Rd, Suite 210, Glendale, California 91208 Phone: (818) 863-6050 |
Superior Hospice Care, Inc. Medicare Approved Location: 1241 S. Glendale Ave, Suite 304d, Glendale, California 91205 Phone: (818) 405-9470 |
Metro Medical Services, Inc Medicare Approved Location: 1616 Victory Blvd, Suite 204, Glendale, California 91201 Phone: (818) 546-8662 |
News Archive
ASD, schizophrenia and bipolar disorder share etiologic risk factors
New research led by a medical geneticist at the University of North Carolina School of Medicine points to an increased risk of autism spectrum disorders (ASDs) among individuals whose parents or siblings have been diagnosed with schizophrenia or bipolar disorder.
Depression negatively impacts outcomes of care in patients with CRS: New research
Depression is a common problem in patients with chronic rhinosinusitis and negatively impacts patients' symptom burden, ability to function, and quality of life, according to new research published in the March 2011 issue of Otolaryngology - Head and Neck Surgery.
Clinical trial to examine use of biomarkers to advance treatment of malignant gliomas launched
The Brain Tumor Unit at the Moores UCSD Cancer Center at the University of California, San Diego in La Jolla, is launching a clinical trial that will examine the use of biomarkers to advance the treatment of malignant gliomas, brain tumors that start in the brain or spinal cord tissue. Annually, about 17,000 Americans are diagnosed with gliomas, which are difficult to treat and often fatal.
Results from Access' MuGard Phase 4 trial on oral mucositis
ACCESS PHARMACEUTICALS, INC., a biopharmaceutical company developing treatments in areas of oncology and oncology supportive care, announced that Dr. Ron R. Allison of Carolina Radiation Medicine, Greenville, NC, presented results from its ongoing MuGard Phase 4 clinical trial in oral mucositis (OM) at the Multinational Association of Supportive Care in Cancer (MASCC) Conference in New York City.
NHS Supply Chain signs deal to purchase 10 Elekta Synergy radiation therapy treatment systems
NHS Supply Chain will bring state-of-the-art cancer treatment to the United Kingdom by signing a deal to purchase ten Elekta Synergy radiation therapy treatment systems.
› Verified 1 days ago
- 1
- 2(current)